Iruzubieta, P, Verdú-Díaz, J, Töpf, A, Luce, L, Claeys, KG, De Ridder, W, González-Quereda, L, de la Hoz, CPD, Poza, JJ, Zulaica, M, de Jonghe, P, Duff, J, Mroczek, M, Martín-Jiménez, P, Hernández-Laín, A, Domínguez-González, C, Baets, J, Gallano, P, Díaz-Manera, J, Straub, V, de Munain, AL, Fernandez-Torron, R. Clinical and imaging spectrum of non-congenital dominant ACTN2 myopathy. JOURNAL OF NEUROLOGY. 2025; 272(2)DOI:10.1007/s00415-025-12893-9. PMID:39812845. IF:4.600(Q1/2D).

Gutiérrez-Muñoz, C, Blázquez-Serra, R, San Sebastian-Jaraba, I, Sanz-Andrea, S, Fernández-Gómez, MJ, Nuñez-Moreno, G, Mínguez, P, Escolá-Gil, JC, Nogales, P, Ollivier, V, Martín-Ventura, JL, Noe, BHT, Rescher, U, Méndez-Barbero, N, Blanco-Colio, LM. Annexin A8 deficiency delays atherosclerosis progression. Clinical and Translational Medicine. 2025; 15(1)DOI:10.1002/ctm2.70176. PMID:39835780. IF:6.800(Q1/2D).

Canyelles M, Blanco-Vaca F, Pérez A, Escolà-Gil JC. Comment on Huh et al. Remnant Cholesterol Is an Independent Predictor of Type 2 Diabetes: A Nationwide Population-Based Cohort Study. Diabetes Care 2023;46:305-312.. DIABETES CARE. 2023; 46(10)DOI:10.2337/dc23-0774. PMID:37729500. IF:(Q/D).

Teis A, Castelblanco E, Cediel G, Amigó N, Julve J, Ribalta J, Guardiola M, Franch J, Bermúdez-López M, Codina P, Lupón J, Mauricio D, Alonso N, Bayés-Genís A. (1)H-magnetic resonance spectroscopy lipoprotein profile in patients with chronic heart failure versus matched controls.. REVISTA ESPANOLA DE CARDIOLOGIA. 2022; 75(11)DOI:10.1016/j.rec.2021.09.008. PMID:34716123. IF:(Q/D).

Llena-Meler, M, Canfran-Duque, A, Madrigal-Matute, J, Rotllan, N. Lipid metabolic alterations in cancer: Common pathophysiology with cardiovascular disease. SEMINARS IN CANCER BIOLOGY. 2026; 119DOI:10.1016/j.semcancer.2026.01.003. PMID:41520912. IF:15.700(Q1/1D).

Mallén, A, Rotllan, N, Griñán, R, Varela, C, Bertolino, E, Paloschi, V, Maegdefessel, L, Escolà-Gil, JC, Aran, JM, Sbraga, F, Blasco-Lucas, A, Torras, J, Navarro, E, Hueso, M. In vivo inhibition of miR-125b-5p modulates monocyte trafficking through the CCR7 receptor and reduces atherosclerosis. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY. 2026; 330(1)DOI:10.1152/ajpcell.00242.2025. PMID:41289597. IF:4.700(Q1/1D).

Chaparro-Cabanillas, N, Pedragosa, J, Núñez-Moyano, H, Escolà-Gil, JC, Planas, AM. Effects of Chronic High-Fat Diet and Pemafibrate Treatment on Stroke Outcomes. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM. 2025; 45(1)DOI:. PMID:. IF:4.500(Q1/2D).

Mercè, F, Asla, Q, Illana, FJ, Victòria, F, Javier, HL, Marta, S, Iglesias, C, Webb, SM, Aulinas, A. A novel likely pathogenic germline variant in CDKN1B in a patient with MEN4 and medullary thyroid cancer. Familial Cancer. 2025; 24(1)DOI:10.1007/s10689-025-00449-9. PMID:40009226. IF:2.000(Q3/7D).

Téllez, L, Donate, J, Guerrero, A, Beraza, IA, San Martín, D, Alvarado, E, Echevarria, V, Puente, A, Zamora, J, Del Prado, S, Tenes, A, Balagué, G, Vidal, B, Geli, C, Rodriguez-Gandia, MA, Baiges, A, Brujats, A, Rodríguez, DLH, Sánchez, SFG, Fortea, JI, del Cerro, MJ, Villanueva, C, Garcia-Pagán, JC, Giráldez, A, Albillos, A. Early portopulmonary hypertension predicts mortality in patients with cirrhosis: Insights from the PORTO-DETECT cohort. JOURNAL OF HEPATOLOGY. 2026; 84(2)DOI:10.1016/j.jhep.2025.09.011. PMID:41076090. IF:33.000(Q1/1D).

Arguello-Tomas, M, Lynton-Pons, E, Albiol, N, Lopez-Ferrer, A, Sierra, J, Moga, E, Moreno, C. Clinical and immunologic characteristics of nonhematologic autoimmune disorders in chronic lymphocytic leukemia. CANCER. 2025; 131(24)DOI:10.1002/cncr.70216. PMID:41378669. IF:5.100(Q1/3D).

Rudler, M, Gea, VH, Larrue, H, Bouzbib, C, Procopet, B, Baiges, A, Turon, F, Villanueva, C, Albillos, A, Tapias, EA, Gluud, LL, Praktiknjo, M, Genesca, J, Ventura-Cots, M, Villagrasa, A, Rodrigues, S, Mouri, S, Giráldez-Gallego, A, Ridaura, HM, Laleman, W, Bureau, C, Robic, MA, Hartl, L, Tellez, L, Zipprich, A, Canete, N, Sultanik, P, Deckmyn, O, Mandorfer, M, Senzolo, M, Schepis, F, Tripathi, D, Pagan, JCG, Thabut, D. Pre-emptive TIPS should be considered in high-risk patients with both acute variceal bleeding and severe alcohol-related hepatitis. Jhep Reports. 2025; 7(12)DOI:10.1016/j.jhepr.2025.101611. PMID:41362711. IF:7.500(Q1/2D).

Serra, E, Cantó, E, Gely, C, Pont, M, Trincado, J, Crespo, M, Vidal, S, Puig, L. Baseline Plasma Protein Signatures and Differential Molecular Responses to Dupilumab in Atopic Dermatitis Patients. JOURNAL OF INVESTIGATIVE DERMATOLOGY. 2025; 145(12)DOI:. PMID:. IF:5.700(Q1/1D).

Martín-Aguilar, L, Blanco-Sanromán, N, Appiani, FE, Caballero-Avila, M, Vidal, N, Martínez-Martínez, L, Querol, L, Vidal-Jordana, A. Personalized dosing in MS: extended interval dosing of ocrelizumab, a real-world observational study. Multiple Sclerosis Journal. 2025; 31(3)DOI:. PMID:. IF:5.000(Q1/2D).

Osuna-Gómez, R, Zamora, C, Novelli, S, Garcia-Pallarols, F, Rodriguez, Y, Domingo, A, Canet, M, Olivera, P, Mulet, M, Cantó, E, Valcarcel, D, Sanchez-Gonzalez, B, Vidal, S. Interplay of leucocyte-platelet complexes and clinical response to eltrombopag in immune thrombocytopenia patients. BRITISH JOURNAL OF HAEMATOLOGY. 2025; 206(4)DOI:10.1111/bjh.19779. PMID:39327831. IF:3.800(Q1/3D).

Arguello-Tomas, M, Mozas, P, Albiol, N, López-Esteban, M, Sierra, J, Nomdedéu, J, Martinez-Laperche, C, Moga, E, Piñeyroa, JA, Delgado, J, Osorio, S, Moreno, C. Risk scores predicting disease progression in early-stage CLL: Comparative analysis and usefulness of IGHV subset #2 to improve their accuracy. CANCER. 2025; 131(1)DOI:10.1002/cncr.35552. PMID:39264834. IF:5.100(Q1/3D).

Laghi L, Román E, Lan Q, Nieto JC, Canalda-Baltrons A, Poca M, Sánchez-Rodríguez MB, Clària J, Alvarado E, Cuyàs B, Sánchez E, Vidal S, Guarner C, Escorsell À, Manichanh C, Soriano G. A multistrain probiotic increases the serum glutamine/glutamate ratio in patients with cirrhosis: a metabolomic analysis.. Hepatology Communications. 2023; 7(4)DOI:10.1097/HC9.0000000000000072. PMID:37026745. IF:5.600(Q1/2D).

Lima, RA, Desoye, G, Simmons, D, van Poppel, MNM, Corcoy R., Adelantado J.M., Jelsma, Judith G.M.. Mediators of lifestyle intervention effects on neonatal adiposity: are we missing a piece of the puzzle?. PEDIATRIC RESEARCH. 2022; 91(3)DOI:10.1038/s41390-021-01450-5. PMID:33753890. IF:3.600(Q1/2D).

Rodríguez-Padial L, Pérez A, Anguita Sánchez M, Barrios V, Gimeno-Orna JA, Muñiz J. Characteristics of women with type 2 diabetes and heart failure in Spain. The DIABET-IC study.. Cardiology Journal. 2024; 31(1)DOI:10.5603/CJ.a2023.0016. PMID:36896635. IF:1.900(Q3/6D).

Monroy G, Fernández C, Olmo R, Martínez MJ, DE Leiva A, Corcoy R. Breastfeeding is associated with a delayed decrease in postprandial maternal glucose concentration.. Minerva Endocrinology. 2023; 48(4)DOI:10.23736/S2724-6507.23.03962-3. PMID:37158811. IF:(Q/D).

Ortega E, Vlacho B, Treserres RP, Mata-Cases M, Altes A, Mauricio D, Franch-Nadal J. Severe hypertriglyceridemia prevalence at a primary care setting in Catalonia, Spain.. Journal of Clinical Lipidology. 2023; 17(6)DOI:10.1016/j.jacl.2023.09.002. PMID:37741728. IF:(Q/D).